Pegasystems to Exhibit in Booth #939 at the 46th Annual DIA Meeting
Pegasystems Inc., (NASDAQ: PEGA), the leader in Business Process Management (BPM) software solutions, today announced it will exhibit at the upcoming 46th DIA Annual Meeting on June 13-17, 2010, in Washington, D.C. Pegasystems, which is expanding its presence in this market, will be on-hand at Booth #939 for this event focused on discovery, development, and life-cycle management of pharmaceuticals, medical devices, and related life sciences products.
Pegasystems counts several leading global life sciences companies as customers. These world-class organizations have leveraged Pegasystems’ SmartBPM® technology to successfully streamline processes within research and development, manufacturing, and sales and marketing. Among its many business benefits for life sciences organizations, SmartBPM technology enables quicker time to market, and more effective risk and compliance practices by automating even the most complex business processes.
Pegasystems also announced that it has appointed Melonie C. Warfel to lead its industry solutions team in the life sciences market. As director of industry solutions for life sciences, Warfel is responsible for leading business strategies, vertical solutions and program execution. Previously, she worked for Adobe Systems, Inc., where she led strategic and operations planning for the company’s life sciences and manufacturing markets. A seasoned veteran with nearly 20 years of experience, Warfel has been instrumental in standards-development activities related to global PDF-based regulatory submissions, PDF/A (ISO 19005-1) for long-term archiving and preservation; and PDF Healthcare (AIIM/ASTM BP01-2008) ,a best practices guide for utilizing PDF within the healthcare industry.
Melonie C. Warfel, Director of Life Sciences Industry Solutions at Pegasystems:
"At a time when life sciences organizations are being challenged to meet ever-changing regulations and complex guidelines, Pegasystems helps eliminate risks, drive operational efficiencies and meet diverse global requirements. Our Build for Change® technology provides the ability to directly manage validation activities and projects within the same system, automatically produce system documentation and audit information, allowing organizations to more easily bring safe and effective products to market in a compliant environment."
For more information on Pegasystems’ expertise in life sciences, download this white paper: https://www.pega.com/content/summary.asp?ci=564
Pegasystems (NASDAQ: PEGA) develops strategic applications for marketing, sales, service, and operations. Pega’s applications streamline critical business operations, connect enterprises to their customers seamlessly in real-time across channels, and adapt to meet rapidly changing requirements. Pega’s Global 3000 customers include many of the world’s most sophisticated and successful enterprises. Pega’s applications, available in the cloud or on-premises, are built on its unified Pega 7 platform, which uses visual tools to easily extend and change applications to meet clients’ strategic business needs. Pega’s clients report that Pega gives them the fastest time to value, extremely rapid deployment, efficient re-use, and global scale. For more information, please visit us at www.pega.com.
All trademarks are the property of their respective owners.
The information contained in this press release is not a commitment, promise, or legal obligation to deliver any material, code or functionality. The development, release and timing of any features or functionality described remains at the sole discretion of Pegasystems, Pegasystems specifically disclaims any liability with respect to this information.
Lisa Pintchman Rogers
VP, Corporate Communications
Director, Corporate Communications
Sr. Manager, Public Relations
Director, Corporate Communications
+44 (0) 118 9651 660
PR & Communications Manager
+44 (0) 118 9398 584
One Rogers St.
Cambridge, MA 02142
Phone +1 617-374-9600
Fax +1 617-374-9620